Alejandro Toro-Pedroza/X
Oct 12, 2025, 07:31
Alejandro Toro-Pedroza Celebrates a Transformative Learning Journey at Yale Cancer Center
Alejandro Toro-Pedroza, Medical Intern atUniversidad Icesi, shared a post on X:
“Month one at Yale Cancer Center (Hematology Clinical Elective) and I can’t overstate how much I’ve learned. From fascinating cases to inspiring mentors, this has been truly a transformative experience. Now looking forward to month two in Rheumatology. Excited for what’s ahead.”
Stay informed with Hemostasis Today.
-
Sep 18, 2026, 15:54Swapnil Pawar: Why Aren’t We Using Cryopreserved Platelets Everywhere Yet?
-
Sep 18, 2026, 15:37Abdul Mannan: Evaluating Longitudinal Platelet Trends Beyond Standard Reference Intervals
-
Sep 18, 2026, 15:30Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
-
Sep 18, 2026, 15:25Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research
-
Sep 18, 2026, 15:01A. M. Thirugnanam: Antiplatelet Discontinuation and the Risk of Stent Thrombosis
-
Sep 18, 2026, 14:52Abdul Muqtadir Abbasi: How Do Hematologists Know Which Coagulation Factor Is the Problem?
-
Sep 18, 2026, 14:48Kato Ramaekers: Redefining Integrin αIIbβ3 in Platelet Formation
-
Sep 18, 2026, 14:33Heghine Khachatryan: The discussion of Thrombophilia, APS and Coagulation Testing
-
Sep 18, 2026, 14:27Maria Cherska: Are We Overlooking the Spleen in Cardiometabolic Research?